针对CCL2-CCR2信号通路:除了心血管疾病之外,他类药物的潜在影响
Hanieh Gholamalizadeh1, Behzad Ensan1, Vasily N Sukhorukov2
1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
The Journal of pharmacy and pharmacology
|December 21, 2023
概括
类药物,或HMG-COA减少酶抑制剂,可以抑制CCL2-CCR2信号通路. 这表明他类药物在各种非心血管疾病中的潜在治疗应用.
科学领域:
- 生物医学研究生物医学研究
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 在许多疾病过程中,CCL2/CCR2信号通路至关重要.
- 抑制这种途径是关键的治疗策略.
- 以降胆固醇功效而闻名的他类药物,还具有正在研究中的额外的类特性.
研究的目的:
- 审查他类药物对CCL2和CCR2表达的影响.
- 探索他类药物在非心血管疾病中的治疗潜力.
主要方法:
- 在Scopus和PubMed上进行了系统的文献搜索.
- 其中的关键词包括"CCL2"",CCR2"",单细胞化学吸引蛋白-1"",HMG-COA减少酶抑制剂"和"他".
- 包括专注于非心血管疾病的研究.
主要成果:
- 类药物通常对CCL2和CCR2表达具有抑制作用.
- 这种效应在各种疾病中观察到,包括免疫介导疾病,病,糖尿病,类风湿性疾病,神经炎症,炎症性肠道疾病,妇科疾病和癌症.
- 大多数证据来自实验模型.
结论:
- 类药物在CCL2-CCR2轴上表现出抑制作用.
- 这表明他类药物可以被开发为非心血管疾病的治疗方法,可能是组合疗法.
- 由于实验数据占主导地位,需要进一步的临床研究.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
667
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667
Cholesterol: Significance and Regulation
551
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
551
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inflammation
53.4K
Overview
53.4K


